Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorNigde Omer Halisdemir University
About this trial
When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.
Eligibility criteria
Qualifiers
To apply to the neurology outpatient clinic, to be a female between the ages of 18-65 who has been diagnosed with MS by a physician
Not being in the attack period
Not being in menopause Not being diagnosed with any autoimmune system disease other than -MS that may adversely affect the study,
Not following the Mediterranean diet and intermittent fasting programmes in the last three months,
Disqualifiers
Having a diagnosis of autoimmune system disease that may adversely affect working outside of -MS,
To be in the attack period-Being under 18 years of age and over 65 years of age
Being in menopause-Mediterranean diet and intermittent fasting feeding programmes within the last three months,
Diet therapy that has an effect on the autoimmune system within the last three months,
Trial design
Treatments tested in this trial
- application of different types of diet
Treatment groups
34 Participants
are divided into 2 treatment groupsSponsors and collaborators
Nigde Omer Halisdemir University
Lead sponsor
Acibadem University
Collaborator
Source ClinicalTrials.gov